Background Image
Table of Contents Table of Contents
Previous Page  60 / 74 Next Page
Information
Show Menu
Previous Page 60 / 74 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 30, No 2, March/April 2019

126

AFRICA

systolic blood pressure by 2–8 mmHg.

92

The key messages are

presented in Table 3.

Conclusion

The measurement of blood pressure in pregnancy and in

HDP requires careful consideration of physiological changes in

pregnancy and a need to be mindful of acute severe systolic and/

or diastolic hypertension. An appropriate device must be used to

ensure that an accurate blood pressure reading is obtained. Poor

technique will lead to medical error. Manufacturer-, patient-,

health system- and healthcare professional-related challenges

that affect blood pressure measurement in pregnancy and HDP

need to be addressed, and the recommendations provided in

the current review may be helpful to clinicians and healthcare

administrators.

References

1.

Brown M, Magee LA, Kenny LC, Karumanchi SA, McCarthy F, Saito

S,

et al

. The hypertensive disorders of pregnancy: ISSHP classification,

diagnosis and management recommendations for international practice.

Pregnancy Hypertens

2018 May 23 pii: S2210-7789(18)30126-0 doi:

101016/jpreghy201805004 [Epub ahead of print].

2.

Alkema L, Chou D, Hogan D, Zhang S, Moller AB, Gemmill A,

et al

.

Global, regional, and national levels and trends in maternal mortal-

ity between 1990 and 2015, with scenario-based projections to 2030:

a systematic analysis by the UN Maternal Mortality Estimation Inter-

Agency Group.

Lancet

2016;

387

(10017): 462–474.

3.

World Health Organization. World health statistics 2016: monitor-

ing health for the SDGs, sustainable development goals. Geneva,

Switzerland: World Health Organization, 2016.

4.

National Committee on the Confidential Enquiries into Maternal

Deaths. Saving Mothers 2014–2016: Seventh triennial report on confi-

dential enquiries into maternal deaths in South Africa: Short report.

Pretoria: South African Department of Health, 2018.

5.

Nyfløt LT, Ellingsen L, Yli BM, Øian P, Vangen S. Maternal deaths

from hypertensive disorders: lessons learnt.

Acta Obstet Gynecol Scand

2018 Apr 17 doi: 101111/aogs13357 [Epub ahead of print].

6.

Magee LA, von Dadelszen P, Stones W, Mathai M.

The FIGO Textbook

of Pregnancy Hypertension: An Evidence-based Guide to Monitoring,

Prevention and Management

. 2016; Available from:

http://www.safe

-

motherhood.ucsf.edu/wp-content/uploads/2013/01/FIGO-Pregnancy_

Hypertension-Final.pdf (assessed 24 July 2017).

7.

Bhatt H, Siddiqui M, Judd E, Oparil S, Calhoun D. Prevalence of pseu-

doresistant hypertension due to blood pressure measurement technique

in a hypertension specialty clinic.

J Am Soc Hypertens

2016;

10

(4):

e20–e21.

8.

Ray G, Nawarskas J, Anderson J. Blood pressure monitoring technique

impacts hypertension treatment.

J Gen Intern Med

2012;

27

(6): 623–629.

9.

Armstrong R. Nurses’ knowledge of error in blood pressure measure-

ment technique.

Int J Nurs Pract

2002;

8

(3): 118–126.

10. Woolsey S, Brown B, Ralls B, Friedrichs M, Stults B. Diagnosing hyper-

tension in primary care clinics according to current guidelines.

J Am

Board Fam Med

2017;

30

(2): 170–177.

11. Poppas A, Shroff SG, Korcarz CE, Hibbard JU, Berger D, Lindheimer

MD,

et al

. Serial assessment of the cardiovascular system in normal

pregnancy. Role of arterial complianceand pulsatile arterial load.

Circulation

1997;

95

(10): 2407.

12. Hibbard JU, Korcarz CE, Nendaz GG, Lindheimer MD, Lang RM,

Shroff SG. The arterial system in pre-eclampsia and chronic hyperten-

sion with superimposed pre-eclampsia.

Br J Obstet Gynaecol

2005;

112

(7): 897–903.

13. Association for the Advancement of Medical Instrumentation,

American National Standards Institute, International Organization for

Standardization. Non-invasive sphygmomanometers: Part 2: Clinical

investigation of automated measurement type ANSI/AAMI/ISO 81060.

2nd edn. Arlington, VA: AAMI, 2013.

14. O’Brien E, Petrie J, Littler W, de Swiet M, Padfield P, Altman D,

et al.

The British Hypertension Society protocol for the evaluation of blood

pressure measuring devices.

J Hypertens

1993;

11

(Suppl 2): S43–S62.

15. O’Brien E, Atkins N, Stergiou G, Karpettas N, Parati G, Asmar R,

et al

.

European Society of Hypertension International Protocol revision 2010

for the validation of blood pressure measuring devices in adults.

Blood

Press Monit

2010;

15

(1): 23–38.

16. Sharman JE, Avolio A, Baulmann J, Benetos A, Blacher J, Blizzard

CL,

et al

. Validation of non-invasive central blood pressure devices:

ARTERY Society task force consensus statement on protocol standardi-

zation.

Eur Heart J

2017;

38

(37): 2805–2812.

17. Stergiou GS, Alpert B, Mieke S, Asmar R, Atkins N, Eckert S,

et al.

A universal standard for the validation of blood pressure measuring

devices: Association for the Advancement of Medical Instrumentation/

European Society of Hypertension/International Organization for

Standardization (AAMI/ESH/ISO) Collaboration Statement.

J

Hypertens

2018;

36

(3): 472–478.

18. Ngene NC, Moodley J. Baseline check of blood pressure readings of

an automated device in severe pre-eclampsia and healthy normotensive

pregnancy.

Pregnancy Hypertens

2018;

12

: 47–52.

19. Camara-Lemarroy CR, Escobedo-Zúñiga N, Villarreal-Garza

E, García-Valadez E, Góngora-Rivera F, Villarreal-Velázquez HJ.

Posterior reversible leukoencephalopathy syndrome (PRES) associated

with severe eclampsia: Clinical and biochemical features.

Pregnancy

Hypertens

2017;

7

: 44–49.

20. Martin JN Jr, Thigpen BD, Moore RC, Rose CH, Cushman J, Warren

M. Stroke and severe preeclampsia and eclampsia: a paradigm shift

focusing on systolic blood pressure.

Obstet Gynaecol

2005;

105

(2):

246–254.

21. Kajantie E, Eriksson J, Osmond C, Thornburg K, Barker D.

Pre-eclampsia is associated with increased risk of stroke in the adult

offspring: the Helsinki birth cohort study.

Stroke

2009;

40

(4): 1176–1180.

22. Leffert L, Clancy C, Bateman B, Bryant A, Kuklina E. Hypertensive

disorders and pregnancy-related stroke.

Obstet Gynecol

2015;

125

(1):

124–131.

23. Auger N, Fraser WD, Paradis G, Healy-Profitós J, Hsieh A, Rhéaume

M-A. Pre-eclampsia and long-term risk of maternal retinal disorders.

Obstet Gynaecol

2017;

129

(1): 42–49.

24. Soma-Pillay P, Suleman FE, Makin JD, Pattinson RC. Cerebral white

matter lesions after pre-eclampsia.

Pregnancy Hypertens

2017; Published

Table 3. Key messages

• Due to physiological changes that occur in pregnancy and in HDP, blood

pressure devices require validation in these conditions to avoid medical error.

• During a blood pressure measurement, an average of two or more readings

should be used to denote the blood pressure value.

• The use of a single blood pressure reading in clinical practice is widespread

and may impact on decision making and compromise patient safety.

• Manufacturer, patient, heath system, and healthcare professional’s related

factors must be addressed to maximise the value of blood pressure measure-

ment.

• An evidence-based and easy-to-follow algorithm on techniques of ausculta-

tory and automated BP measurement is provided in the article (Table 1).